Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb665f2ec3690d6a793a0a10e8377e0c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fff4b69c11017edfbbdfd8973bfb75e2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3371a5692148c7be8fe2a89d92eb817b |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00452 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00765 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0448 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-044 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7084 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-325 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B18-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M- |
filingDate |
2004-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1335dd7bb8445cc54e50d1a742dfc589 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0852fc65d96e0a60d3dbac175ca0a19c |
publicationDate |
2005-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2005056075-A2 |
titleOfInvention |
Transdermal system for sustained delivery of polypeptides |
abstract |
The present invention relates to a transdermal system for sustained delivery of high molecular weight hydrophilic drugs, especially peptide-, polypeptide- or protein-drugs and to methods of use thereof. The system comprises an apparatus that generates micro-channels in the skin of a subject in conjunction with a transdermal patch comprising at least one drug reservoir layer comprising a polymeric matrix and a therapeutic or immunogenic peptide, polypeptide or protein. The system provides sustained delivery of therapeutic or immunogenic agents, thereby achieving sustained therapeutic blood concentrations of these agents. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007077487-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104271149-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104271149-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014008369-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2359877-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2008598-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013136234-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7558625-B2 |
priorityDate |
2003-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |